From: TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer
Clinicopathologic features | No. of patients | TM4SF1 expression | p | ||
---|---|---|---|---|---|
Positive | Negative | ||||
Age (years) | ≥60 | 40 | 25 | 15 | 0.784 |
< 60 | 32 | 21 | 11 | ||
Gender | Male | 45 | 31 | 14 | 0.254 |
Female | 27 | 15 | 12 | ||
Sizes | < 3 | 32 | 17 | 15 | 0.089 |
> 3 | 40 | 29 | 11 | ||
Pathologic T stage | T1 + T2 | 30 | 14 | 16 | 0.01* |
T3 + T4 | 42 | 32 | 10 | ||
Vascular invasion | Yes | 50 | 33 | 17 | 0.60 |
No | 22 | 13 | 9 | ||
Lymph node metastasis | Yes | 47 | 35 | 12 | 0.01* |
No | 25 | 11 | 14 | ||
Tumor differentiation | Poorly | 20 | 16 | 4 | 0.37 |
Moderate | 36 | 24 | 12 | ||
Well | 16 | 6 | 10 | ||
Liver metastasis | Yes | 31 | 24 | 7 | 0.038* |
No | 41 | 22 | 19 |